Notice of Closed Meeting, 55298 [2020-19549]
Download as PDF
<![CDATA[
55298
Federal Register / Vol. 85, No. 173 / Friday, September 4, 2020 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
Centers for Disease Control and
Prevention
jbell on DSKJLSW7X2PROD with NOTICES
Notice of Closed Meeting
16:42 Sep 03, 2020
[FR Doc. 2020–19675 Filed 9–3–20; 8:45 am]
BILLING CODE 4163–18–P
[FR Doc. 2020–19549 Filed 9–3–20; 8:45 am]
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control, Special Emphasis Panel
(SEP)—RFA–PS–21–001, Minority HIV
Research Initiative (MARI) to Support
Epidemiologic and Implementation
Science Research in Racial/Ethnic
Minority Communities
Disproportionately Affected by HIV and
Build Research Capacity Among
Historically Underrepresented
Researchers.
Date: December 15–16, 2020.
Time: 10:00 a.m.–5:00 p.m., EST.
Place: Teleconference, Centers for
Disease Control and Prevention, Room
1080, 8 Corporate Square Boulevard,
Atlanta, GA 30329.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road NE, Mailstop US8–1,
Atlanta, Georgia 30329–4027, (404) 718–
8833, GAnderson@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
VerDate Sep<11>2014
Dated: September 1, 2020.
Sandra Cashman,
Executive Secretary, Centers for Disease
Control and Prevention.
Jkt 250001
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Centers for Disease Control and
Prevention
Proposed Information Collection
Activity; Advance Planning Document
(APD) Process (OMB #0970–0417)
Performance Review Board Members
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
Notice.
The Centers for Disease
Control and Prevention (CDC) located
within the Department of Health and
Human Services (HHS) is publishing the
names of the Performance Review Board
Members who are reviewing
performance of Senior Executive Service
(SES) members, Title 42 (T42)
executives, and Senior Level (SL)
employees for Fiscal Year 2020.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Henry Greene, Team Chief, Executive
and Scientific Resources Office, Human
Resources Office, Centers for Disease
Control and Prevention, 11 Corporate
Square Blvd., Mailstop US11–2, Atlanta,
Georgia 30341, Telephone (770) 488–
1140.
Title 5,
U.S.C. Section 4314(c) (4) of the Civil
Service Reform Act of 1978, Public Law
95–454, requires that the appointment
of Performance Review Board Members
be published in the Federal Register.
The following persons will serve on the
CDC Performance Review Board, which
will oversee the evaluation of
performance appraisals of Senior
Executive Service members for the
Fiscal Year 2020 review period:
SUPPLEMENTARY INFORMATION:
Dean, Hazel, Co-Chair
Shelton, Dana, Co-Chair
Wharton, Melinda
Dulin, Stephanie
Ethier, Kathleen
Kitt, Margaret
Kosmos, Christine
Peeples, Amy
Perry, Terrance
Pirkle, James
Schluter, William W.
Smagh, Kalwant
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Office of Child Support
Enforcement, Administration for
Children and Families, Health and
Human Services (HHS).
ACTION: Request for public comment.
AGENCY:
The Administration for
Children and Families’ (ACF) Office of
Child Support Enforcement (OCSE) is
requesting an update to the existing data
collection for the Advance Planning
Document (APD) process (OMB #0970–
0417). OCSE proposes revisions to the
annual burden estimates to reflect an
increase in the number of states seeking
approval to implement modernization
solutions in efforts to replace antiquated
legacy child support enforcement
systems and to address an excess
demand for emergency funding requests
due to the impacts of the COVID–19
pandemic.
DATES: Comments due within 60 days of
publication. In compliance with the
requirements of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
ACF is soliciting public comment on the
specific aspects of the information
collection described above.
ADDRESSES: Copies of the proposed
collection of information can be
obtained and comments may be
forwarded by emailing infocollection@
acf.hhs.gov. Alternatively, copies can
also be obtained by writing to the
Administration for Children and
Families, Office of Planning, Research,
and Evaluation (OPRE), 330 C Street
SW, Washington, DC 20201, Attn: ACF
Reports Clearance Officer. All requests,
emailed or written, should be identified
by the title of the information collection.
SUPPLEMENTARY INFORMATION:
Description: The APD process,
established at 45 CFR part 95, subpart
F, is the procedure by which states
request and obtain approval for Federal
Financial Participation (FFP) in their
cost of acquiring Automated Data
Processing (ADP) equipment and
services.
SUMMARY:
E:\FR\FM\04SEN1.SGM
04SEN1
]]>Agencies
[Federal Register Volume 85, Number 173 (Friday, September 4, 2020)]
[Notices]
[Page 55298]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-19549]
[[Page 55298]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control, Special Emphasis Panel (SEP)--RFA-PS-21-001, Minority HIV
Research Initiative (MARI) to Support Epidemiologic and Implementation
Science Research in Racial/Ethnic Minority Communities
Disproportionately Affected by HIV and Build Research Capacity Among
Historically Underrepresented Researchers.
Date: December 15-16, 2020.
Time: 10:00 a.m.-5:00 p.m., EST.
Place: Teleconference, Centers for Disease Control and Prevention,
Room 1080, 8 Corporate Square Boulevard, Atlanta, GA 30329.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600 Clifton Road NE, Mailstop US8-1,
Atlanta, Georgia 30329-4027, (404) 718-8833, [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-19549 Filed 9-3-20; 8:45 am]
BILLING CODE 4163-18-P
